REIT - Healthcare Facilities
Compare Stocks
3 / 10Stock Comparison
VTR vs WELL vs HR
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
VTR vs WELL vs HR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $41.26B | $150.14B | $6.95B |
| Revenue (TTM) | $6.13B | $11.63B | $1.15B |
| Net Income (TTM) | $260M | $1.43B | $-201M |
| Gross Margin | -4.3% | 39.1% | -9.7% |
| Operating Margin | 13.4% | 4.4% | 19.5% |
| Forward P/E | 118.3x | 78.9x | — |
| Total Debt | $13.22B | $21.38B | $4.15B |
| Cash & Equiv. | $741M | $5.03B | $26M |
VTR vs WELL vs HR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Ventas, Inc. (VTR) | 100 | 248.3 | +148.3% |
| Welltower Inc. (WELL) | 100 | 422.9 | +322.9% |
| Healthcare Realty T… (HR) | 100 | 64.9 | -35.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VTR vs WELL vs HR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VTR is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 1 yrs, beta 0.01, yield 2.1%
- Beta 0.01, yield 2.1%, current ratio 0.96x
- Beta 0.01 vs HR's 0.13
WELL carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 230.2% 10Y total return vs VTR's 67.4%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
HR is the clearest fit if your priority is dividends.
- 5.6% yield, vs WELL's 1.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs HR's -6.9% | |
| Value | Better valuation composite | |
| Quality / Margins | 12.3% margin vs HR's -17.5% | |
| Stability / Safety | Beta 0.01 vs HR's 0.13 | |
| Dividends | 5.6% yield, vs WELL's 1.3% | |
| Momentum (1Y) | +43.9% vs VTR's +33.2% | |
| Efficiency (ROA) | 2.3% ROA vs HR's -2.1%, ROIC 0.5% vs 0.7% |
VTR vs WELL vs HR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
VTR vs WELL vs HR — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
WELL leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 10.1x HR's $1.1B. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to HR's -17.5%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $6.1B | $11.6B | $1.1B |
| EBITDAEarnings before interest/tax | $2.3B | $2.8B | $767M |
| Net IncomeAfter-tax profit | $260M | $1.4B | -$201M |
| Free Cash FlowCash after capex | $1.4B | $2.5B | $201M |
| Gross MarginGross profit ÷ Revenue | -4.3% | +39.1% | -9.7% |
| Operating MarginEBIT ÷ Revenue | +13.4% | +4.4% | +19.5% |
| Net MarginNet income ÷ Revenue | +4.2% | +12.3% | -17.5% |
| FCF MarginFCF ÷ Revenue | +22.4% | +21.9% | +17.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +22.0% | +40.3% | -10.5% |
| EPS Growth (YoY)Latest quarter vs prior year | 0.0% | +22.5% | +99.8% |
Valuation Metrics
HR leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 154.2x trailing earnings, WELL trades at a 4% valuation discount to VTR's 160.7x P/E. On an enterprise value basis, HR's 16.8x EV/EBITDA is more attractive than WELL's 66.8x.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $41.3B | $150.1B | $6.9B |
| Enterprise ValueMkt cap + debt − cash | $53.7B | $166.5B | $11.1B |
| Trailing P/EPrice ÷ TTM EPS | 160.70x | 154.17x | -28.06x |
| Forward P/EPrice ÷ next-FY EPS est. | 118.34x | 78.89x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — |
| EV / EBITDAEnterprise value multiple | 24.36x | 66.76x | 16.80x |
| Price / SalesMarket cap ÷ Revenue | 7.07x | 14.08x | 5.89x |
| Price / BookPrice ÷ Book value/share | 3.19x | 3.37x | 1.49x |
| Price / FCFMarket cap ÷ FCF | 31.34x | 52.72x | 54.74x |
Profitability & Efficiency
WELL leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-4 for HR. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to VTR's 1.05x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs VTR's 6/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +2.1% | +3.5% | -4.3% |
| ROA (TTM)Return on assets | +1.0% | +2.3% | -2.1% |
| ROICReturn on invested capital | +2.5% | +0.5% | +0.7% |
| ROCEReturn on capital employed | +3.2% | +0.6% | +1.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 7 |
| Debt / EquityFinancial leverage | 1.05x | 0.49x | 0.89x |
| Net DebtTotal debt minus cash | $12.5B | $16.3B | $4.1B |
| Cash & Equiv.Liquid assets | $741M | $5.0B | $26M |
| Total DebtShort + long-term debt | $13.2B | $21.4B | $4.1B |
| Interest CoverageEBIT ÷ Interest expense | 1.40x | 0.26x | -0.21x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $31,264 today (with dividends reinvested), compared to $10,343 for HR. Over the past 12 months, WELL leads with a +43.9% total return vs VTR's +33.2%. The 3-year compound annual growth rate (CAGR) favors WELL at 41.3% vs HR's 5.2% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +12.9% | +15.0% | +18.9% |
| 1-Year ReturnPast 12 months | +33.2% | +43.9% | +39.1% |
| 3-Year ReturnCumulative with dividends | +93.0% | +182.2% | +16.4% |
| 5-Year ReturnCumulative with dividends | +80.0% | +212.6% | +3.4% |
| 10-Year ReturnCumulative with dividends | +67.4% | +230.2% | +42.2% |
| CAGR (3Y)Annualised 3-year return | +24.5% | +41.3% | +5.2% |
Risk & Volatility
Evenly matched — VTR and HR each lead in 1 of 2 comparable metrics.
Risk & Volatility
VTR is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than HR's 0.13 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.01x | 0.13x | 0.13x |
| 52-Week HighHighest price in past year | $88.50 | $219.59 | $20.03 |
| 52-Week LowLowest price in past year | $61.76 | $142.65 | $14.09 |
| % of 52W HighCurrent price vs 52-week peak | +98.1% | +97.6% | +99.5% |
| RSI (14)Momentum oscillator 0–100 | 62.0 | 62.6 | 72.2 |
| Avg Volume (50D)Average daily shares traded | 3.3M | 2.6M | 3.4M |
Analyst Outlook
Evenly matched — WELL and HR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: VTR as "Buy", WELL as "Buy", HR as "Hold". Consensus price targets imply 5.7% upside for WELL (target: $227) vs -3.0% for HR (target: $19). For income investors, HR offers the higher dividend yield at 5.55% vs WELL's 1.29%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $90.80 | $226.50 | $19.33 |
| # AnalystsCovering analysts | 32 | 34 | 29 |
| Dividend YieldAnnual dividend ÷ price | +2.1% | +1.3% | +5.6% |
| Dividend StreakConsecutive years of raises | 1 | 2 | 0 |
| Dividend / ShareAnnual DPS | $1.86 | $2.76 | $1.11 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.1% |
WELL leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HR leads in 1 (Valuation Metrics). 2 tied.
VTR vs WELL vs HR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VTR or WELL or HR a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -6. 9% for Healthcare Realty Trust Incorporated (HR). Welltower Inc. (WELL) offers the better valuation at 154. 2x trailing P/E (78. 9x forward), making it the more compelling value choice. Analysts rate Ventas, Inc. (VTR) a "Buy" — based on 32 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VTR or WELL or HR?
On trailing P/E, Welltower Inc.
(WELL) is the cheapest at 154. 2x versus Ventas, Inc. at 160. 7x. On forward P/E, Welltower Inc. is actually cheaper at 78. 9x.
03Which is the better long-term investment — VTR or WELL or HR?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +212. 6%, compared to +3. 4% for Healthcare Realty Trust Incorporated (HR). Over 10 years, the gap is even starker: WELL returned +230. 2% versus HR's +42. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VTR or WELL or HR?
By beta (market sensitivity over 5 years), Ventas, Inc.
(VTR) is the lower-risk stock at 0. 01β versus Healthcare Realty Trust Incorporated's 0. 13β — meaning HR is approximately 1306% more volatile than VTR relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 105% for Ventas, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VTR or WELL or HR?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus -6. 9% for Healthcare Realty Trust Incorporated (HR). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VTR or WELL or HR?
Welltower Inc.
(WELL) is the more profitable company, earning 8. 8% net margin versus -20. 8% for Healthcare Realty Trust Incorporated — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VTR leads at 14. 2% versus 3. 3% for WELL. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VTR or WELL or HR more undervalued right now?
On forward earnings alone, Welltower Inc.
(WELL) trades at 78. 9x forward P/E versus 118. 3x for Ventas, Inc. — 39. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WELL: 5. 7% to $226. 50.
08Which pays a better dividend — VTR or WELL or HR?
All stocks in this comparison pay dividends.
Healthcare Realty Trust Incorporated (HR) offers the highest yield at 5. 6%, versus 1. 3% for Welltower Inc. (WELL).
09Is VTR or WELL or HR better for a retirement portfolio?
For long-horizon retirement investors, Ventas, Inc.
(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 2. 1% yield). Both have compounded well over 10 years (VTR: +67. 4%, HR: +42. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VTR and WELL and HR?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: VTR is a mid-cap high-growth stock; WELL is a mid-cap high-growth stock; HR is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.